1. Home
  2. OSRH vs AIMD Comparison

OSRH vs AIMD Comparison

Compare OSRH & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

HOLD

Current Price

$0.55

Market Cap

11.7M

Sector

N/A

ML Signal

HOLD

AIMD

Ainos Inc.

N/A

Current Price

$1.44

Market Cap

9.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OSRH
AIMD
Founded
N/A
1984
Country
United States
United States
Employees
21
44
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
9.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OSRH
AIMD
Price
$0.55
$1.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
707.2K
20.1K
Earning Date
05-19-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$0.44
52 Week High
$2.72
$4.50

Technical Indicators

Market Signals
Indicator
OSRH
AIMD
Relative Strength Index (RSI) 52.16 45.71
Support Level $0.39 $1.33
Resistance Level $0.74 $1.72
Average True Range (ATR) 0.06 0.11
MACD 0.01 0.01
Stochastic Oscillator 50.22 30.16

Price Performance

Historical Comparison
OSRH
AIMD

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.

Share on Social Networks: